Cancer Research UK - Plans for £200m NHS England cancer investment announced
Spending plans for new investment in NHS radiotherapy machines and £200m to improve local cancer services in England have been announced (link is external).
NHS England’s chief executive, Simon Stevens, has announced the first hospitals to benefit from the major national investment in radiotherapy machines, alongside £200m of funding over two years.
Mr Stevens said the money would be used in England to increase efforts in diagnosing cancers earlier and support plans to help people live with and beyond cancer.
Following the recent announcement that £130m will be invested in new radiotherapy machines, Stevens also unveiled 15 hospitals that will be the first to have the latest machines installed.
The sites are:
- North Cumbria University Hospitals NHS Trust
- The Newcastle upon Tyne Hospitals NHS Foundation Trust
- Lancashire Teaching Hospitals NHS Foundation Trust
- The Clatterbridge Cancer Centre NHS Foundation Trust
- University Hospitals Birmingham NHS Foundation Trust
- University Hospitals Coventry and Warwickshire NHS Trust
- Maidstone and Tunbridge Wells NHS Trust
- University Hospital Southampton NHS Foundation Trust
- University Hospitals Bristol NHS Foundation Trust
- Torbay and South Devon NHS Foundation Trust
- Royal Surrey County Hospital NHS Foundation Trust
- University College London Hospitals NHS Foundation Trust
- University Hospitals of Leicester NHS Trust
- Hull and East Yorkshire Hospitals NHS Trust
- Sheffield Teaching Hospitals NHS Foundation Trust
Stevens said the locations for the new machines had been selected based on where the need was greatest.
Emma Greenwood, Cancer Research UK's director of policy and public affairs, welcomed the “vital investment to transform patient care across the country”.
Stevens said the £200m fund hopes to encourage local areas to find new ways to diagnose cancer earlier, improve support for those living with cancer, and ensure each patient gets the right care for them.
The latest data show national one-year survival for all cancers has risen to 70.4%, while survival for breast, colorectal and lung cancer individually have also risen.
The variation in survival between different parts of the country has also shrunk, according to the latest figures.
“The earlier we diagnose and treat cancer, the better the chance of survival. But nearly half of all UK patients are diagnosed when their cancer is at a later stage, with variation across the country,” said Greenwood.
“This transformation funding will help improve diagnostic services, enabling patients to benefit from the latest treatments as early as possible.”
But Greenwood added that it is important to use this investment to tackle staff issues within diagnostic services in the NHS.
“We urge the NHS to ensure that a significant part of this investment is targeted to addressing staff shortages, as our recent research has shown we need a better equipped diagnostic workforce to face the challenge of increasing incidence.”
Latest News from
Age UK comments on Dispatches investigation into Bupa care homes20/06/2017 12:35:00
Age UK has commented on the Channel 4 Dispatches programme from Monday 19 June 2017, 'Bupa Care Homes Undercover'.
Care system 'buckling' says Age UK as major care homes investigation launches15/06/2017 10:35:00
A recent study into the quality of care homes which has sparked a much wider legal investigation has been called 'a manifestation of our buckling social care system' by Age UK.
Diabetes UK - Brits failing to meet the recommended daily allowance of fruit and veg13/06/2017 09:35:00
A new survey* commissioned by Diabetes UK to promote its Food you love healthy eating campaign in Diabetes Week (Sunday 11 June to Saturday 17 June), has found that 66 per cent of adults eat three or fewer portions of fruit and/or vegetables a day – well below the recommended five portions - and 46 per cent won’t eat any fruit at least three days a week.
CRUK - Combining immunotherapies could benefit some aggressive breast cancers09/06/2017 10:15:00
Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.
CRUK - Two clinical trials show promise with different targeted drugs for lung cancer07/06/2017 14:10:00
Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available, according to unpublished clinical trials.
CRUK - New chemotherapy approach offers breast cancer patients a better quality of life07/06/2017 12:10:00
The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative regimen called CMF, when given following epirubicin.
CRUK - Adding abiraterone to standard treatment improves prostate cancer survival by 40 per cent06/06/2017 10:35:00
Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent, according to the results of one of the largest ever clinical trials for prostate cancer presented at the 2017 ASCO Annual Meeting in Chicago and published in the New England Journal of Medicine on Saturday.
British Red Cross - Manchester attack – What happens after05/06/2017 16:15:00
An edition of the BRC’s Newsthink encourages young people to consider ways that the public helped each other after the explosion. It also explores the role of practical help and emotional support during and after an emergency.